TRIM41-Mediated Ubiquitination of Nucleoprotein Limits Vesicular Stomatitis Virus Infection
出版年份 2020 全文链接
标题
TRIM41-Mediated Ubiquitination of Nucleoprotein Limits Vesicular Stomatitis Virus Infection
作者
关键词
-
出版物
Viruses-Basel
Volume 12, Issue 2, Pages 131
出版商
MDPI AG
发表日期
2020-01-23
DOI
10.3390/v12020131
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Tripartite motif proteins: an emerging antiviral protein family
- (2019) Girish Patil et al. Future Virology
- TRIM41-Mediated Ubiquitination of Nucleoprotein Limits Influenza A Virus Infection
- (2018) Girish Patil et al. JOURNAL OF VIROLOGY
- RINCK-mediated monoubiquitination of cGAS promotes antiviral innate immune responses
- (2018) Zhao-Shan Liu et al. Cell and Bioscience
- Influenza A Virus–Host Protein Interactions Control Viral Pathogenesis
- (2017) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Comparative influenza protein interactomes identify the role of plakophilin 2 in virus restriction
- (2017) Lingyan Wang et al. Nature Communications
- Mechanism of TRIM25 Catalytic Activation in the Antiviral RIG-I Pathway
- (2016) Jacint G. Sanchez et al. Cell Reports
- APOBEC3G-Mediated G-to-A Hypermutation of the HIV-1 Genome: The Missing Link in Antiviral Molecular Mechanisms
- (2016) Ayaka Okada et al. Frontiers in Microbiology
- Characterization and Genetic Analyses of New Genes Coding for NOD2 Interacting Proteins
- (2016) Raphaële Thiébaut et al. PLoS One
- TRIM14 inhibits hepatitis C virus infection by SPRY domain-dependent targeted degradation of the viral NS5A protein
- (2016) Shanshan Wang et al. Scientific Reports
- TRIM52 inhibits Japanese Encephalitis Virus replication by degrading the viral NS2A
- (2016) Wenchun Fan et al. Scientific Reports
- Interferon alpha (IFNα)-induced TRIM22 interrupts HCV replication by ubiquitinating NS5A
- (2015) Chen Yang et al. Cellular & Molecular Immunology
- TRIM32 Senses and Restricts Influenza A Virus by Ubiquitination of PB1 Polymerase
- (2015) Bishi Fu et al. PLoS Pathogens
- Overlapping and Distinct Molecular Determinants Dictating the Antiviral Activities of TRIM56 against Flaviviruses and Coronavirus
- (2014) B. Liu et al. JOURNAL OF VIROLOGY
- Improved vectors and genome-wide libraries for CRISPR screening
- (2014) Neville E Sanjana et al. NATURE METHODS
- Implication of PMLIV in Both Intrinsic and Innate Immunity
- (2014) Faten El Asmi et al. PLoS Pathogens
- TRIM22 Inhibits Influenza A Virus Infection by Targeting the Viral Nucleoprotein for Degradation
- (2013) A. Di Pietro et al. JOURNAL OF VIROLOGY
- Identification and Characterization of Multiple TRIM Proteins That Inhibit Hepatitis B Virus Transcription
- (2013) Shijian Zhang et al. PLoS One
- Role of Promyelocytic Leukemia Protein in Host Antiviral Defense
- (2011) Marie-Claude Geoffroy et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- TRIM56 Is a Virus- and Interferon-Inducible E3 Ubiquitin Ligase That Restricts Pestivirus Infection
- (2011) J. Wang et al. JOURNAL OF VIROLOGY
- TRIM5 is an innate immune sensor for the retrovirus capsid lattice
- (2011) Thomas Pertel et al. NATURE
- Pattern Recognition Receptors and Inflammation
- (2010) Osamu Takeuchi et al. CELL
- Recognition of viruses by cytoplasmic sensors
- (2010) Courtney Wilkins et al. CURRENT OPINION IN IMMUNOLOGY
- Tripartite motif-containing 22 inhibits the activity of hepatitis B virus core promoter, which is dependent on nuclear-located RING domain
- (2009) Bo Gao et al. HEPATOLOGY
- TRIM22 E3 ubiquitin ligase activity is required to mediate antiviral activity against encephalomyocarditis virus
- (2009) P. Eldin et al. JOURNAL OF GENERAL VIROLOGY
- Rhabdovirus Evasion of the Interferon System
- (2009) Martina Rieder et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Innate immunity to virus infection
- (2008) Osamu Takeuchi et al. IMMUNOLOGICAL REVIEWS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More